Notice of Proposed Sale · 144
Edwards Lifesciences Corp
EWNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Edwards Lifesciences Corp
- Issuer CIK
- 0001099800
- SEC file number
- 001-15525
- Phone
- 9492502500
- Person for whose account securities are to be sold
- Markowitz Wayne
- Relationships to issuer
- Officer
- Street
- ONE EDWARDS WAY
- City
- IRVINE
- State / country code
- CA
- Postal code
- 92614
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 147 | 12,588.00 | 575,800,000 | 07/30/2026 | NYSE | Charles Schwab & Co., Inc. |
Broker / market maker — proposed row 1, entry 1
- Name
- Charles Schwab & Co., Inc.
- Street
- 3000 Schwab Way
- City
- Westlake
- State / country code
- TX
- Postal code
- 76262
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 03/28/2024 | ESPP - See Remarks | EDWARDS LIFESCIENCES CORPORATION | 147 | N | 03/28/2024 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| WAYNE MARKOWITZ | Edwards Lifesciences Corp | 05/11/2026 | 593 | 47,280.00 |
| WAYNE MARKOWITZ | Edwards Lifesciences Corp | 07/28/2026 | 9,628 | 818,958.00 |
Seller — prior-sale row 1, entry 1
- Name
- WAYNE MARKOWITZ
- Street
- ONE EDWARDS WAY
- City
- IRVINE
- State / country code
- CA
- Postal code
- 92614
Seller — prior-sale row 2, entry 1
- Name
- WAYNE MARKOWITZ
- Street
- ONE EDWARDS WAY
- City
- IRVINE
- State / country code
- CA
- Postal code
- 92614
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The shares reported in this filing were acquired and sold between 03/28/2024 and 12/31/2024.
Notice signature
- Notice date
- 07/30/2026
- Signed
- WAYNE MARKOWITZ
Company context
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.